Skip to content

SOL INFI

Active Private limited companyfounded 2024active for 2 yearsRue Joseph Bidez 67, 7080 FrameriesKBO/BCE: BE 1010.350.812

Lifetime

2 annual accounts with figures on one time axis
peak €170,807 (2025)
€170,807▲ 25.6%
peak €59,621 (2025)
€59,621▲ 152%
peak €77,876 (2025)
€77,876▲ 229%
€44,872▲ 134%
Board1 name since 2024
Documentsfilings and deeds
31-08-202631 days late
2025micro format
Turnover from €135,966 to €170,807Gross margin from €39,024 to €95,241Result from €23,655 to €59,621Equity from €23,655 to €77,876Debts from €19,175 to €44,872Investments €3,042

Key points

from the 2025 annual accounts

Equity

€77,876 ▲ 229%
€23,7002024€77,9002025

Equity rose in 2025 from €23,655 to €77,876.

Investments

€3,042 8.1 × depreciation
20242025

Green is investment, beige is depreciation.

Payment terms

3 days to suppliers
Suppliers
15 to 3
Customers
4 to 0

SOL INFI pays its suppliers 12 days earlier than in 2024. Customers pay 4 days earlier.

2025 accounts filed 31 days after the deadline

Checked score

97
Excellent
Financially stronger than 72% of micro companies in human health (NACE 86)
Probability in this band: under 0.55%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

The dashed line is the sector median: < 0.1% across 24,192 companies (NACE 86, micro).

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Last 24 months 07-2025: 0.3%highest value 08-2025: < 0.1%▼ -0.3 percentage points vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026lowest value 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: 0.1%▲ +0.1 percentage points vs 07-2026 09-2026: < 0.1%▼ -0.1 percentage points vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026 11-2026: < 0.1%● unchanged vs 10-2026

Financial strength
Strong

88+8equity 63.4% of total assets
84+6short-term debt 34.9% · cash 94.5%
100=return on assets 48.6%

Score breakdown

raises risk
Founded in 2024
lowers risk
Sector: Human health activities (NACE 86)
Liquidity: current ratio 2.74, cash €116,008
Equity €77,876 (63.4% of total assets)
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 51% of them on solvency, 67% on liquidity, 80% on profitability and 90% on growth.

The bankruptcy probability was computed on 10-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

The probability rests on the annual accounts with balance sheet date 31-12-2025.

Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Comparable companies, two years later

In July 2024, 39,278 companies had the same profile as SOL INFI has now. Each dot stands for 99 companies, two years later.

95.8%
were still trading
2.3%
stopped another way
1.8%
went bankrupt
  • Micro
  • 2 to 5 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more

Another 0.1% stopped without a precise date, possibly only after those two years.

The bankruptcy probability of SOL INFI itself is lower: < 0.1% within 12 months. It rests on far more data about SOL INFI than the profile alone.

Test of the method

The method was tested on the 497,447 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 39,278 companies, not a prediction for SOL INFI. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit of up to €7,000 on 30-day terms, only on tighter conditions: young company (under 3 years) without a track record

Liquidity is ample, with a current ratio of 2.74 (2.09 in 2024), above the usual 1.5. Short-term debt is 34.9% and cash 94.5% of total assets. 36.6% of the assets are financed with debt and provisions.

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskraises risk
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Liquidity: current ratio 2.74, cash €116,008
NBB · annual accounts
lowers risk · Equity €77,876 (63.4% of total assets)
NBB · annual accounts
raises risk · Founded in 2024
Companies of this age fail more often than older ones. How much that weighs depends on the rest of the company's profile.
KBO
raises risk · 2025 accounts filed 31 days late
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 31-08-2026, 31 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 2 filings
Deviation from the deadline
2025
31 days late
2024
21 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 2 accounts on average 5 days after the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Where today falls in the filing period
11-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since incorporation in 2024.
KBO publications

Board and ownership

  • ROUSSEAU Soledad Magaly founderdeed of 17-06-2024
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:1010350812
Incorporation Founder: ROUSSEAU Soledad Magaly · Founding capital of €0, 100 shares · Appointment: ROUSSEAU Soledad Magaly (director) · published on 17-06-2024 · Gazette deed
First establishment Rue Joseph Bidez 67, Frameries
All 5 events

Comparable companies

same main activity, similar in size and age
Company
SOL INFI Frameries €122,747 €95,241 63.4% -
La Vita Nova vroedvrouw Oud-Turnhout €119,487 €103,181 63.1% -
MME MR Chaudfontaine €106,325 €88,011 84.2% -
CURA Aalst €107,329 €87,532 54.3% -
INFIKA Walcourt €121,708 €98,018 61.8% -
MEG SOINS Charleroi €127,384 €81,129 87.6% -
K.A Care Charleroi €126,035 €91,129 53.8% -

These companies have the same main activity as SOL INFI: nursing and midwifery (NACE 86940). They are comparable in size and age: total assets between €106,000 and €127,000, founded between 2023 and 2025.

Official details

Source: KBO
Status
Active since 13-06-2024Normal situation
Activity
Nursing and midwiferyNACE 86940
Establishment unit
2.360.496.9787080 Frameries, since 13-06-2024
Financial year end
31 December
Peppol
Reachable since 27-01-2026
Company details

Annual accounts 2025

€122,747▲ 187%
Filing
Filed on 31-08-2026
Financials

Insights on SOL INFI

Solvency rose in 2025 from 55.2% to 63.4% because of the retained profit.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about SOL INFI

What is the company number of SOL INFI?
The company number of SOL INFI is 1010.350.812. The VAT number is the same number with BE in front: BE 1010.350.812.
Where is SOL INFI based?
The registered office is at Rue Joseph Bidez 67, 7080 Frameries.Company details
What does SOL INFI do?
According to the KBO register, the main activity is nursing and midwifery (NACE 86940).
What is the legal form of SOL INFI?
SOL INFI is a private limited company (BV).
When was SOL INFI founded?
SOL INFI was founded on 13-06-2024.
Is SOL INFI still active?
Yes, SOL INFI is an active enterprise in the KBO register.
What is the turnover of SOL INFI?
The turnover of SOL INFI was €170,807 in financial year 2025, according to the filed annual accounts.Financials
Is SOL INFI profitable?
In financial year 2025, SOL INFI made a profit of €59,621.
Where can I find the annual accounts of SOL INFI?
SOL INFI filed 2 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of SOL INFI due?
SOL INFI must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.